Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 858 | 916 | 858 | 552 | 999 | 1777 |
Fund Return | -14.17% | -8.44% | -14.17% | -17.96% | -0.03% | 5.92% |
Place in category | 70 | 77 | 70 | 77 | 28 | 8 |
% in Category | 43 | 41 | 43 | 65 | 65 | 55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bosera S&P 500 QDII | 15.84B | 25.30 | 11.64 | 13.35 | ||
BoseraYufu CSI 300 Index Fund A | 6.24B | 15.67 | -3.77 | 5.16 | ||
BoseraYufu CSI 300 Index Fund C | 6.24B | 15.21 | -4.15 | - | ||
Bosera Theme Industry Stock FdLOF | 5.37B | -1.08 | -13.24 | 4.20 | ||
Bosera Emerging Growth Fund | 1.85B | 2.52 | -12.99 | 3.89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 32.09B | -16.06 | -20.16 | - | ||
Zhongou Medical and Health Hybrid C | 32.09B | -16.74 | -20.80 | - | ||
E Healthcare Secotor | 5.01B | -10.07 | -6.18 | 9.22 | ||
Fullgoal Precision Medical Mix Fund | 4.18B | -2.79 | -9.55 | - | ||
BOC Innovative Health Care Alloc | 3.01B | -11.52 | -10.97 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Kelun Pharm A | CNE100000PW7 | 6.90 | 28.13 | -0.04% | |
Jiangsu Hengrui | CNE0000014W7 | 5.85 | 44.65 | +0.02% | |
Cr Sanjiu A | CNE0000011K8 | 3.74 | 44.23 | +0.11% | |
Double Medical Tech | CNE1000032W7 | 3.34 | 35.12 | -1.21% | |
Beijing Tongrentang | CNE000000R69 | 3.01 | 36.97 | +0.60% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Strong Sell |
Technical Indicators | BUY | Strong Sell | Strong Sell |
Summary | Neutral | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review